You are here

Novo Nordisk

Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug

Motley Fool

Thu, 05/9/19 - 11:20 pm

oral semaglutide

Renewable Energy Will Power all of Novo Nordisk’s Production Facilities by 2020

BioSpace

Wed, 05/1/19 - 12:10 pm

drug manufacturing

renewable energy

environmental concerns

Novo seeks Victoza label expansion with fresh pediatric trial results

Biopharma Dive

Mon, 04/29/19 - 09:33 pm

type 2 diabetes

Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs

TheStreet.com

Fri, 04/12/19 - 10:05 am

Gilead Sciences

clinical trials

Novo Nordisk seeks FDA nod for oral diabetes pill

Drug Delivery Business News

Thu, 03/21/19 - 09:49 am

Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva

Pharmaceutical Business Review

Wed, 03/20/19 - 12:16 pm

Teva Pharmaceutical

Novo's Victoza won't face Teva copies until 2023. Can semaglutide fill the gap by then?

Fierce Pharma

Mon, 03/18/19 - 05:05 pm

Teva Pharmaceutical

Novo Nordisk Launches Innovation Platform in China

CP Wire

Fri, 03/8/19 - 09:54 am

Novo Nordisk Launches Innovation Platform in China

Fri, 03/8/19 - 09:46 am

In a blockbuster franchise race, Novo’s Trulicity rival scores more promising late-stage diabetes data

Endpoints

Mon, 03/4/19 - 10:20 am

Abbott, Novo Nordisk ink deal for digital diabetes tools

Drug Delivery Business News

Wed, 02/20/19 - 06:13 pm

FreeStyle Libra

connected insulin pen

IP trouble defers launch of Novo's long-acting hemophilia therapy

Endpoints

Wed, 02/20/19 - 10:03 am

With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market

BioSpace

Wed, 02/13/19 - 10:06 am

An oral insulin delivery system inspired by tortoises

Fierce Biotech

Thu, 02/7/19 - 11:19 pm

Brigham and Women's

Mark Your Calendar For These February PDUFA Dates

Yahoo/Benzinga

Sat, 02/2/19 - 12:31 pm

MOTIF BIO PLC/S ADR

Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing

BioSpace

Fri, 02/1/19 - 11:27 am

Novo bets on swift FDA review for oral diabetes drug semaglutide

Endpoints

Fri, 02/1/19 - 09:50 am

On heels of drug pricing hearings, Democratic lawmakers kick off insulin probe

Fierce Pharma

Thu, 01/31/19 - 11:53 pm

Novo Holdings' antibiotic resistance fund backs 3 biotechs

Fierce Biotech

Mon, 01/21/19 - 12:32 pm

antibiotic resistance

Procarta Biosystems

Entasis Therapeutics

Novo Nordisk’s first diabetes innovation challenge winners head to the lab

Fierce Pharma

Sat, 01/5/19 - 01:32 pm

Pages